Pluri Inc. Restricted Cash and Investments, Current
Pluri Inc. (PLUR) had Restricted Cash and Investments, Current of $1.08 million as of 2019-06-30, per its 10-K filed 2019-09-12.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Restricted Cash and Investments, Current
us-gaap:RestrictedCashAndInvestmentsCurrent · last filed 2019-09-12
- 2019-06-30: Restricted Cash and Investments, Current $1.08M.
- 2019-03-31: Restricted Cash and Investments, Current $703.00K.
- 2018-12-31: Restricted Cash and Investments, Current $916.00K.
- 2018-06-30: Restricted Cash and Investments, Current $1.07M.
| Period end | Restricted Cash and Investments, Current |
|---|---|
| 2019-06-30 | $1.08M 10-K · filed 2019-09-12 |
| 2019-03-31 | $703.00K 10-Q · filed 2019-05-06 |
| 2018-12-31 | $916.00K 10-Q · filed 2019-02-06 |
| 2018-06-30 | $1.07M 10-K · filed 2019-09-12 |
| 2018-03-31 | $691.00K 10-Q · filed 2019-05-06 |
| 2017-12-31 | $566.00K 10-Q · filed 2019-02-06 |
| 2017-06-30 | $958.00K 10-K · filed 2019-09-12 |
| 2013-06-30 | $316.00K 10-K · filed 2013-09-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |